Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RU486 in depression.

K R Krishnan1, D Reed, W H Wilson

  • 1Department of Psychiatry, Duke University Medical Center, Durham, NC.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A proof of concept case series of botulinum toxin a treatment for ischemic feet due to Raynaud's phenomenon.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2026
Same author

Sulodexide in venous disease.

Journal of thrombosis and haemostasis : JTH·2018
Same author

A genome-wide association study of antidepressant response in Koreans.

Translational psychiatry·2015
Same author

Clinical science and biomarkers: against RDoC.

Acta psychiatrica Scandinavica·2015
Same author

A genome-wide association study of antidepressant response in Koreans.

Translational psychiatry·2015
Same author

Association of the choline acetyltransferase gene with responsiveness to acetylcholinesterase inhibitors in Alzheimer's disease.

Pharmacopsychiatry·2015
Same journal

Mapping intrinsic neural timescale alterations in major depressive disorder.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Probiotics in reducing negative symptoms of schizophrenia: A systematic review and meta-analysis.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

The IL10 rs1800872 polymorphism differentially modulates the relationship between plasma IL-10 levels and cognitive function in methamphetamine use disorder.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Inflammatory differences and differential response to minocycline augmentation in young adult patients with first-episode drug-naïve melancholic and non-melancholic major depressive disorder.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Beyond gray matter: unveiling the critical role of white matter in Alzheimer's disease.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same journal

Chronic pain and stress: Transdiagnostic meta-analytic evidence of convergent network signature with PTSD.

Progress in neuro-psychopharmacology & biological psychiatry·2026
See all related articles

The synthetic glucocorticoid antagonist RU486 revealed increased hypothalamic-pituitary-adrenal (HPA) activity in depressed patients. This supports the hypothesis of heightened suprahypophyseal stimulation of the anterior pituitary in these individuals.

Area of Science:

  • Neuroendocrinology
  • Psychiatry
  • Pharmacology

Background:

  • Elevated plasma cortisol and ACTH are observed in patients.
  • The underlying cause, specifically suprahypophyseal stimulation, requires investigation.

Purpose of the Study:

  • To test the hypothesis that elevated cortisol and ACTH in patients stem from suprahypophyseal stimulation of the anterior pituitary.
  • To evaluate the effect of RU486 on the hypothalamic-pituitary-adrenal (HPA) axis in depressed patients.

Main Methods:

  • A study involving seven patients and matched controls.
  • Administration of RU486 (a synthetic glucocorticoid antagonist) before and after assessments.
  • Measurement of plasma cortisol and ACTH levels.

Main Results:

Related Experiment Videos

  • RU486 administration led to an increase in HPA activity specifically in depressed patients.
  • The drug's effect provides evidence supporting the proposed mechanism.

Conclusions:

  • The findings support the hypothesis of increased suprahypophyseal stimulation of the anterior pituitary in depressed patients.
  • RU486 can be a valuable tool for probing HPA axis regulation in psychiatric conditions.